Quantum Accounting is pleased to announce the appointment of Mr. Torashi, former CEO of Rakuten Medical K.K., as a new advisor to further strengthen our support for Japanese startups listing on the U.S. stock markets. Together with Mr. Shinohara, former CFO of Kura Sushi USA, who has already joined our team, we now have a comprehensive support system in place for IPO-related measures, including business strategy, capital policy (fundraising), governance structure, and IR strategy.
In addition to traditional accounting support, Quantum Accounting is expanding its expertise to support the entire listing process. With Mr. Torashi joining the team, we will further enhance our ability to support client companies in achieving strategic growth in the global market. We are also strengthening our framework to ensure sustained success after listing, providing comprehensive support.
Mr. Torashi has extensive experience leading global operations at Rakuten Medical, Inc. (headquartered in California), where he successfully raised $450 million in funding, managed multiple clinical trials, and secured product approval in the Japanese market. Leveraging this experience, he will provide broad support to our clients, from developing business strategies, capital policies, and IR strategies necessary for IPOs to post-listing growth strategies.
Quantum Accounting will continue to support Japanese companies in their expansion into global markets, aiming to contribute to our clients’ growth and successful listings.